logo

US7767449B1 Methods using modified vaccinia virus

If you want to confirm some technical details before you order,
just need to send a message or e-mail: [email protected].
Then our professional sales staff will contact you within 2 hours.

vaccinia virus - Translation into French - examples English | Reverso Conte

Translations in context of "vaccinia virus" in English-French from Reverso Context: antibody production in vaccinia virus infected cells Register Login Font size Help English العربية Deutsch English Español Français עברית Italiano 日本語 Nederlands Polski ··· ...

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge .

VP40 and GP inserts were optimized for the codon usage of vaccinia virus and sequences encoding termination of vaccinia transcripts were eliminated by using alternate ...

A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Ca

2 Vaccinia virus and CRISPR Cas-9 M Yuan et al. Molecular Therapy — Methods & Clinical Development (2015) 15035 Official journal of the American Society of Gene & Cell Therapy ReSUlTS Construction of a homologous recombination repair donor vector with an ...

EPO - T 0339/93 (Modified vaccinia virus/HEALTH RESEARCH, INC.) of 18.4.19

Summary of Facts and Submissions I. European patent No. 0 083 286 based on European patent application No. 82 402 380.8 and relating to "Modified vaccinia virus and methods for making and using the same" was granted for eleven Contracting States, with ...

Developing genetically engineered oncolytic viruses for cancer gene thera

DEVELOPING GENETICALLY ENGINEERED ONCOLYTIC VIRUSES FOR CANCER GENE THERAPY Suvi Parviainen Cancer Gene Therapy Group Haartman Institute Medicum Integrative Life Science Doctoral Program Faculty of Medicine University of To be ...

Modified vaccinia virus and methods for making and using the same - HEALTH RESEARCH, INCORPORAT

Abstract not available for EP0083286 Abstract of corresponding document: US4603112 What are disclosed are methods for modifying the genome of vaccinia virus to produce vaccinia mutants, particularly by the introduction into the vaccinia genome of exogenous ...

Research articleCan vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectant

Research articleCan vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants? Holger F Rabenau*1, Ingrid Rapp2 and Jochen Steinmann3 ...

Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 Syst

Vaccinia virus (VACV) continues to be used in immunotherapy for the prevention of infectious diseases and treatment of cancer since its use for the eradication of smallpox. However, the current method of editing the VACV genome is not efficient. Here, we ...

A MODIFIED STRUCTURE AT THE S-TERMINUS OF mRNA OF VACCINIA VIR

Volume 49, number 3 FEBS LETTERS January 1975 A MODIFIED STRUCTURE AT THE S-TERMINUS OF mRNA OF VACCINIA VIRUS Toshiyuki URUSHIBARA*, Yasuhiro FURUICHI, Chiaki NISHIMURA** and Kin-ichiro MIURA National Institute ...

Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an .

Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist Laetitia Fend 1, ...

Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low

Author summary Vaccinia virus is a complex large DNA virus with a large number of viral membrane ... generate mutant and revertant viral genomes by de novo genome assembly but excluding the terminal repeat sequences of vaccinia virus. Using the alignment ...

RESEARCH Open Access Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins .

Methods: We constructed a bivalent recombinant vaccinia virus expressing modified E7E6 fusion proteins of HPV type 16 and 18 (rVVJ16/18E7E6) ...

Pathogen Safety Data Sheets: Infectious Substances – Vaccinia Virus - Canada.

Vaccinia virus is usually injected in the dermis where a localized lesion appears (a "take"), and then scabs over and heals in about 10-14 days Footnote 4. The vaccination is accompanied by fever, ...

Vaccinia - Wikiped

Vaccinia virus (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, and which encodes approximately 250 genes. The dimensions of the virion are roughly ...

Using Vaccinia's innate ability to introduce DNA into mammalian cells for production of recombinant proteins, Journal of ...- DeepDy

Read "Using Vaccinia's innate ability to introduce DNA into mammalian cells for production of recombinant proteins, Journal of Biotechnology" on DeepDyve, the largest online rental service for scholarly research with thousands of academic publications available at ...

Different Types of Vaccines | History of Vaccin

chick embryos). Using chick embryos as an example, the virus is grown in different embryos in a series. ... All of the methods that involve passing a virus through a non-human host produce a version of the virus that can still be recognized by the ...

The mechanisms of genetically modified vaccinia viruses for the treatment of cancer - ScienceDire

This paper will address some of the most common forms of genetically modified vaccinia viruses and will explore the mechanisms whereby they selectively target, ...

Susceptibility of different leukocyte cell types to Vaccinia virus infection | Virology Journal | Full Te

We have investigated the ability of vaccinia virus to infect human PBLs by using virus recombinants expressing green fluorescent protein ... Drillien R, Spehner D, Hanau D: Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. 85: ...

US Patent for Methods using modified vaccinia virus Patent (Patent # 5,972,597 issued October 26, 1999) - Justia Patents Sear

What are disclosed are methods for modifying the genome of vaccinia virus to produce vaccinia mutants, particularly by the introduction into the vaccinia genome of exogenous DNA; modified vaccinia prepared by such methods; certain DNA sequences and ...

Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput Method To .

Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput ... methods to measure anti-vaccinia virus neutralizing antibodies are usually performed using a plaque reduction neutralization ...